Clinical Observation on Clopidogrel and Guanxin Shutong Capsule in the Treatment of Angina Pectoris in Acute Coronary Syndrome after PCI
Patiguli·Abdukadir
Mutijiang·Maimaiti
Abstract：Objective To investigate the effect of clopidogrel and Guanxin Shutong capsule (GSC) in the treatment of angina pectoris in acute coronary syndromes (ACS) after percutaneous coronary intervention (PCI).Methods Eighty patients with ACS after PCI in our hospital from February 2014 to February 2017 were randomly divided into two groups:control group treated with routine treatment,and treatment group treated with routine treatment plus clopidogrel and GSC.The data of the frequency and onset duration of angina pectoris before and after treatment were collected.The levels of high-sensitivity C-reactive protein (hs-CRP) and low-density lipoprotein cholesterol (LDL-C) were measured in patients before and after 20 days of research.The criteria of angina pectoris were established.Results The effective rate of angina pectoris was 95% in treatment group,and 77.5% in control group.The levels of hs-CRP and LDL-C were decreased in two groups after treatment, and the descending condition was more obvious in treatment group.Conclusion Clopidogrel and GSC can decrease the levels of hs-CRP and LDL-C,improve the rate of angina pectoris and control the frequency and duration of angina pectoris in patients with ACS after PCI.
Keywords：Acute Coronary Syndroneseizure frequencyangina pectorisGuanxin Shutong capsuleclopidogrelhith-sensitivity C-reactive protein
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 1893-1896 )